Abstract
Endosomal trafficking is an essential component of the CD1 pathway of lipid antigen presentation to T cells. We demonstrate that CD1d access to endosomal compartments is under dual regulation by an intrinsic tyrosine-based motif, which governs intense recycling between the plasma membrane and the endosome, and by the invariant chain, with which CD1d associates in the endoplasmic reticulum. Both pathways independently enhance antigen presentation to Vα14+ NKT cells, the main subset of CD1d-restricted T cells. These results reveal the complexity of CD1d trafficking and suggest that the invariant chain was a component of ancestral antigen presentation pathways prior to the evolution of MHC and CD1.
Original language | English |
---|---|
Pages (from-to) | 897-908 |
Number of pages | 12 |
Journal | Immunity |
Volume | 15 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2001 |
Bibliographical note
Funding Information:We thank S. Amigorena, C. Bonnerot, F. Castellino, C. Forestier, R. Germain, B. Jabri, L. Karlsson, I. Mellman, L. Teyton, H. Vincent-Schneider, G. Waters, and M. Weigert for helpful discussions, reagents, and technical advice, J. Goodhouse for help with confocal microscopy, and A. Beavis for assistance with flow cytometry. This work was supported by grants from the National Institutes of Health and the American Cancer Society, by a Leukemia and Lymphoma Society fellowship (to K.B), and by a Cancer Research Institute fellowship (to Y.-H.C).
Funding
We thank S. Amigorena, C. Bonnerot, F. Castellino, C. Forestier, R. Germain, B. Jabri, L. Karlsson, I. Mellman, L. Teyton, H. Vincent-Schneider, G. Waters, and M. Weigert for helpful discussions, reagents, and technical advice, J. Goodhouse for help with confocal microscopy, and A. Beavis for assistance with flow cytometry. This work was supported by grants from the National Institutes of Health and the American Cancer Society, by a Leukemia and Lymphoma Society fellowship (to K.B), and by a Cancer Research Institute fellowship (to Y.-H.C).
Funders | Funder number |
---|---|
National Institutes of Health | |
American Cancer Society | |
Cancer research institute | |
Leukemia and Lymphoma Society |